LongevityLow Risk

Vilon

Also known as: Lys-Glu, Khavinson immune dipeptide

Half-life:: Unknown

Administration Routes

subcutaneous injectionintramuscular injection

PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Mechanism of Action

Synthetic dipeptide Lys-Glu; modulates T-cell and NK cell activity; reduces age-related immune decline; normalizes cytokine production via epigenetic gene regulation

A Khavinson immune dipeptide bioregulator. Restores immune function independently of thymic action, particularly effective in elderly populations with involuted thymuses.

Primary Research Areas

immune modulation
anti-aging
immune restoration
longevity

Risk Profile

Low Risk

Generally considered lower risk in research contexts. Consult a healthcare professional before use.

Regulatory Status

Research OnlyNot Evaluated by FDA

Russian dipeptide bioregulator (Lys-Glu) from Khavinson Institute. Immunomodulatory and longevity research. Not FDA-approved. Not on any FDA list. Research chemical in US.

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Where to Find Vilon

No active associated providers listed yet.